Ignite Creation Date:
2025-12-24 @ 2:17 PM
Ignite Modification Date:
2025-12-26 @ 4:11 PM
Study NCT ID:
NCT01193595
Status:
COMPLETED
Last Update Posted:
2014-12-03
First Post:
2010-08-31
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Dose-escalation, Safety, Pharmacokinetics Study of AVE8062 Combined With Bevacizumab in Patients With Advanced Solid Tumors
Sponsor:
Sanofi
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-09
Start Date Type:
None
Primary Completion Date:
2014-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-10
Completion Date Type:
ACTUAL
First Submit Date:
2010-08-31
First Submit QC Date:
None
Study First Post Date:
2010-09-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-12-02
Last Update Post Date:
2014-12-03
Last Update Post Date Type:
ESTIMATED